[ad_1]
A new study published Monday in the medical journal Annals of Internal Medicine came to a different conclusion.
The study found that aspirin reduces the risk of heart problems in at-risk patients and in some patients with no known risk of cardiovascular disease. The researchers concluded that the benefits of aspirin outweigh the harms of bleeding, if one compared the risk of bleeding deaths to that of hospitalization or death by cardiac event. .
According to the study, at least 12.1% of men and 2.5% of women with no history of heart problems had a net benefit of five years of aspirin treatment. The percentage of benefit increases even more if you compare the risk of two hemorrhagic events to two cardiovascular events.
Researchers understood this by looking at data from more than 245,000 healthy adults aged 30 to 79 in New Zealand.
Although the authors conclude that for some people without heart disease, aspirin is "likely to generate a net benefit," they warn that further research will be needed to see if this would apply to people living outside of the community. New Zealand. They also did not study the use of aspirin in people over 79 years old.
The study adds that, if "aspirin is likely to generate a net benefit", it is "difficult" to make a general recommendation in this regard.
Kevin McConway, emeritus professor of applied statistics at the Open University, agrees with their caution.
"Methods of estimating the risk of [cardiovascular disease] and significant bleeds are based on New Zealand data and could give inappropriate numbers for the risks faced by other populations, "said McConway, who was not affiliated with research, at Science Media Center of the United Kingdom to transmit the results of New Zealand to other populations without further research.
Similar conclusions, different interpretation
Although the results are similar, these studies came to a different conclusion and argued that a daily aspirin-based regimen did not present any significant benefit to the health of the elderly and could be harmful. According to Khera, what is very different is the interpretation of the risk of hemorrhage. Unlike the authors of this study, he thinks the harm is too serious.
"It's not a nosebleed, it's serious bleeding that requires hospitalization and transfusions," Khera said.
"In the past, when patients considered using aspirin daily, we usually answered yes, sometimes no, now when people ask it, it's usually no, you should not take it and, on the occasion, it's a yes, it's a lot more beautiful balance now, "Khera said. "It can help people who have had heart attacks and strokes, but usually healthy people, for most people it does not do them any favors, taking aspirin."
Selak, who wrote the new study, points out the limit in this decision.
"There is clearly an advantage of aspirin in terms of reducing the risk of [cardiovascular disease] These events are based on a recently published meta-analysis of all relevant trials on aspirin in people without CVD, "said Selak.The challenge is that aspirin also increases the risk of" high blood pressure. " major haemorrhages.
"What our study has shown is that there are people likely to benefit overall from aspirin, taking into account the damage associated with bleeding, but a personalized prediction of the pros and cons is needed to identify these people. "
[ad_2]
Source link